SIX2 Promotes Cell Plasticity via Wnt/β-Catenin Signaling in Androgen Receptor Independent Prostate Cancer

The authors examined the chromatin landscape of androgen receptor (AR)-positive prostate cancer cells post-exposure to the AR inhibitor enzalutamide.